Shares of Krishna Institute of Medical Sciences (KIMS) surged nearly 6 percent on November 11 after the company reported strong financial results for the second quarter of FY25.
By 12:50 PM, KIMS’ share price was up 3 percent, trading at Rs 587. The stock has gained over 50 percent year-to-date, significantly outperforming the Nifty 50, which rose 12 percent during the same period.
KIMS posted a consolidated net profit of Rs 107.4 crore for Q2FY25, marking a 24 percent increase from the previous quarter and a 16.7 percent rise year-over-year. Revenue from operations also saw growth, reaching Rs 777.3 crore, up 13 percent sequentially and 19 percent compared to the previous year.
The company’s EBITDA showed a strong rise, increasing 21.2 percent quarter-over-quarter and 23.8 percent year-over-year to Rs 223 crore. The EBITDA margin improved to 28.5 percent in Q2FY25, compared to 27.5 percent in Q2FY24 and 26.6 percent in the prior quarter.
CMD B Bhaskar Rao said, “The second quarter has been pretty productive, with our Nashik unit commencing operations and opening first hospital in Kerala at Kannur. All our units are working at full capacity to meet the patient demand. Our endeavour of providing affordable, quality healthcare is on target and we firmly believe of achieving the targets for the FY25 targets.
KIMS Hospitals operates a chain of 16 hospitals with more than 5,000 beds across the states of Telangana, Andhra Pradesh, Maharashtra, and, more recently, Kerala. The hospitals are multispecialty hospitals focused on offering comprehensive tertiary care to the patients in cardiac sciences, oncology, neurosciences, and organ transplantation.
Do you have a news tip for Lakshmishree reporters? Please email us at media@lakshmishree.com
Source: Moneycontrol
News Desk
